COVID-19 has been the rudest wake-up call to the importance of biomedical research. One in 200 diseases known to science have meaningful treatments, while drug candidates face a 10,000-to-one odds...

[BERLIN] German biotech firm Curevac said on Friday it had won nearly US$300 million in government funding to speed up work on its prototype Covid-19 vaccine and build capacity to produce it at...

[HONG KONG] Brii Biosciences, which focuses on treatments for diseases such as Covid-19 and HIV, is considering an initial public offering (IPO) in Hong Kong as soon as the first quarter of next...

IN certain sectors in Asia, a speculative fervour has taken hold, particularly among retail investors.

[FRANKFURT] Bayer agreed to acquire British biotech firm KaNDy Therapeutics Ltd for an initial US$425 million to strengthen its women's healthcare business with a prospective non-hormonal...

[TEL AVIV] Israel's largest venture capital (VC) investor in life sciences, AMoon, boosted the size of its biggest fund to US$750 million after demand for new healthcare technology rose during the...

[FRANKFURT] GSK is to buy a 10 per cent stake in German biotech company CureVac for £130 million (S$227.5 million), the two companies said on Monday, in a deal that bets on new technologies...

A SOUTH KOREAN steelmaker that controls a biotech firm is trying again to secure a listing in Singapore for the biotech firm by a backdoor route.

A SOUTH KOREAN steelmaker that controls a kimchi lactobacillus (lactic acid bacteria) biotech firm is trying again to secure a listing in Singapore for the latter, via the judicial management...

[BEIJING] Shares in Chinese biotechnology company Beigene jumped the most in eight months after Hillhouse Capital invested about US$1 billion in the largest equity financing ever by a biotech...